Steve Jobs, Apple Inc.’s iconic co-founder and CEO, received a liver transplant during his medical leave of absence about two months ago, according to reports.
The Wall Street Journal reported the procedure on Saturday, followed by Bloomberg and CNBC. Naming unidentified sources, Jobs is recovering well and is set to return to his daily functions as a CEO at the end of this month.
Jobs has been integral to Apple’s success and is considered central to the company’s vision. He returned in 1997 to the company he founded and led Apple to become a major player in the personal computer market and a pioneer in the portable music market as well as the smartphone market. Its products’ minimalistic designs have been the envy of its competitors.
That’s why in January, when Apple announced that Jobs would take a medical leave from the company, its stock shares slid more than 7 percent almost immediately.
Jobs underwent treatment for a rare form of pancreatic cancer in 2004 and was cured of the ailment, the company disclosed in August 2004.
Last year, there was speculation that his health was worsening as he appeared to be thinner by the month. Apple said the weight loss was due to a hormonal imbalance.
Some analysts suggest that Jobs should relinquish his role as CEO to avoid such media and Wall Street's scrutiny on his health condition. Company COO Timothy Cook headed the company in Jobs’s absence and is expected to serve a bigger role even after Jobs returns.